Concepedia

Hirotsugu Tanaka

HT

Statistics

Publications

10

Citations

970

H-Index

10

Active since

2006

Affiliations

Astellas Pharma (Japan)(Current)

Tokyo University of Science

The University of Tokyo

National Institute of Information and Communications Technology

Hirotsugu Tanaka is an author at Astellas Pharma (Japan) specializing in endocrinology, pharmacology, and diabetes mellitus.

Publications per year

2006–2013

10

Publications

10

Selective elimination of messenger RNA prevents an incidence of untimely meiosis

Yuriko Harigaya, Hirotsugu Tanaka, Soichiro Yamanaka et al. · Nature · 2006 · 319 citations

, , +16

Discovery of Novel Forkhead Box O1 Inhibitors for Treating Type 2 Diabetes: Improvement of Fasting Glycemia in Diabetic db/db Mice

Takeyuki Nagashima, Nobuharu Shigematsu, Riyo Maruki et al. · Molecular Pharmacology · 2010 · 277 citations

, , +13

Hexanucleotide motifs mediate recruitment of the RNA elimination machinery to silent meiotic genes

Akira Yamashita, Yuichi Shichino, Hirotsugu Tanaka et al. · Open Biology · 2012 · 110 citations · Full text

, , +11

AS1907417, a novel GPR119 agonist, as an insulinotropic and β-cell preservative agent for the treatment of type 2 diabetes

S. Yoshida, Hirotsugu Tanaka, Hiroyuki Oshima et al. · Biochemical and Biophysical Research Communications · 2010 · 55 citations

, , +13

Enhanced insulin secretion and sensitization in diabetic mice on chronic treatment with a transient receptor potential vanilloid 1 antagonist

Hirotsugu Tanaka, Akiyoshi Shimaya, Tetsuo Kiso et al. · Life Sciences · 2011 · 45 citations

, , +17

1–5 of 10